Skip to main content

Lactoferrin amyloid presenting as a mural nodule in a pancreatic cystic lesion prompting pancreatoduodenectomy: a case report

Abstract

Background

Amyloid deposition in pancreas is rare. Lactoferrin amyloid deposition has not been reported in pancreas, till date. Presence of enhancing mural nodule in a cyst on imaging is a worrisome feature for malignancy, and warrants surgical resection in a surgically fit candidate, as per Fukuoka guidelines for management of cystic lesions in pancreas.

Case report

We report a case of localized amyloidosis presenting as a mural nodule in a 1.6 cm cyst located in the head of pancreas, which led to pancreatoduodenectomy in a 69 year old woman. Histological evaluation revealed a simple mucinous cyst with localized lactoferrin amyloid deposition corresponding to the mural nodule identified on imaging.

Conclusions

We report the first case of localized lactoferrin amyloid deposition in pancreas that presented as a mural nodule in a cystic lesion and prompted pancreatoduodenectomy. This unique case illustrates that on rare occasion mural nodule in a cyst can be benign. It adds amyloid deposition to the differential diagnosis of mural nodules in pancreatic cystic lesions seen on imaging.

Peer Review reports

Background

Amyloidosis arises from disordered protein metabolism in which normally soluble proteins undergo conformational changes causing insolubility and extracellular deposition [1]. Amyloid deposition can occur in almost every organ in the body with particularly common occurrence in the liver, kidneys, and skin [1,2,3]. Amyloid deposition in pancreas is rare [4,5,6,7,8]. Systemic amyloidosis can uncommonly involve the pancreas, and is incidentally detected on autopsy as this does not lead to functional abnormalities of exocrine or endocrine function [9]. Localized amyloid deposition in the islets of Langerhans is more frequent in the pancreas in patients with diabetes mellitus. The type of amyloid fibril in this setting is islet amyloid polypeptide (IAPP). The only pancreatic tumor associated with amyloidosis is Insulin expressing pancreatic neuroendocrine tumor, which is rarely associated with IAPP-type amyloidosis [8].

Lactoferrin is an iron binding protein present in the granules of polymorphonuclear leukocytes (PML) [10,11,12,13]. Upon activation of PMLs, lactoferrin is excreted with the intention of binding free iron that is needed for bacterial growth. Lactoferrin as a precursor protein of localized amyloidosis is rare and has only been reported as isolated cases in conjunctiva, cornea, seminal vesicles and bronchus [14,15,16,17]. Amyloid lactoferrin has never been reported in the pancreas to the best of our knowledge. Herein, we report a novel case of localized lactoferrin amyloidosis manifesting as a mural nodule in a 1.6 cm pancreatic cystic lesion, detected on endoscopic ultrasound (EUS) imaging. Presence of lymphadenopathy on imaging and “atypical cells” on fine needle aspiration cytology of nodule categorized the lesion as a “mucinous cyst with worrisome features” [18], and prompted pancreatoduodenectomy.

Case presentation

A 69 year old Caucasian female with a past history of ocular melanoma was found to have an incidental 1.6 × 1.6 × 0.7 cm hypodense lesion in the head of the pancreas, on surveillance computed tomographic (CT) scanning of the abdomen (Fig. 1a). In addition, there was a single enlarged porta hepatis lymph node measuring 2.8 × 1 cm. The patient was asymptomatic and without any prior episodes of pancreatitis.

Fig. 1
figure1

a CT scan demonstrating an indeterminate hypodense area in the pancreatic head (arrows) (axial view). b MRI scan demonstrating the lobulated cyst with eccentric mural nodule in the head of the pancreas with effacement of the distal common bile duct. Associated atrophy of the body and tail of the pancreas (axial view). c EUS showing cyst wall with mural nodule (arrow)

Additional imaging studies were performed to characterize the lesion. Magnetic resonance imaging (MRI) demonstrated the 1.7 × 1.3 cm lobulated lesion with effacement of the distal CBD (Fig. 1b). Endoscopic ultrasound (EUS) confirmed the 1.5 × 1.4 cm hypoechoic lesion suggestive of a cyst, which did not show communication with the pancreatic duct. EUS further demonstrated thickened cyst wall with mural nodule and presence of luminal debris (Fig. 1c). The mural nodule measured 0.8 × 0.7 cm. Vascularity of the nodule on EUS was not assessed. Fine needle aspiration of the cyst revealed turbid, viscous fluid, however the pathology evaluation was inconclusive. Post-EUS, the patient developed right upper quadrant abdominal pain, with post-prandial worsening, and was associated with dark colored urine and acholic stools. Due to concern for extrinsic compression on the CBD, the patient underwent ERCP, which identified a 7 mm single area of stenosis in the CBD that was relieved with placement of a plastic stent. Following stent placement, her blood work and symptoms normalized. She underwent repeat EUS with FNA of mural nodule. The FNA cytologic evaluation revealed atypical cells. Clinically, the cyst was considered to be an intraductal papillary mucinous neoplasm or mucinous cystic neoplasm. Considering the worrisome features of lymphadenopathy on imaging studies and atypical cells on FNA cytology of mural nodule, a decision was made to resect the lesion. Pancreas protocol CT scan performed prior to surgery showed a vague hypodense area in the pancreatic head, likely collapse of the cyst following aspiration, and a decompressed biliary tree. Pancreatic duct was not dilated, however, there was distal pancreas atrophy. A pylorus preserving pancreaticoduodenectomy was performed.

Gross evaluation of the pancreas revealed a 1.6 × 1.1 × 1 cm uniloculated cystic lesion in the head of the pancreas. The cyst did not show communication with the main pancreatic duct. The cystic lesion was completely excised and all margins were negative. The entire lesion was submitted for histological evaluation. Microscopic evaluation showed a unilocular cyst lined by gastric type mucinous epithelium (Fig. 2a). No papillary projection or configuration was seen. Immunohistochemical stains showed the cyst wall lining to be diffusely positive for MUC5AC, and focally positive for MUC 6. The mucinous lining was negative for MUC1 and MUC2 (Fig. 2b–e). The histological features were consistent with a simple mucinous cyst. No dysplasia or carcinoma was seen. There was focal thickening in the cyst wall with intraluminal nodular lesion characterized by amorphous eosinophilic congophilic material consistent with amyloid, surrounded by foreign body type giant cell reaction and chronic inflammation composed of lymphocytes and polyclonal plasma cells (Fig. 3a–d). Upon further evaluation of congo red stain, the amyloid deposits showed characteristic apple green birefringence on polarizing microscopy, and red fluorescence on fluorescent microscopy using Texas Red filter (Fig. 3e). This focus correlated with the mural nodule seen on EUS. Laser microdissection (LMD)-liquid chromatography-tandem mass spectroscopy (LC–MS) confirmed the amyloid to be lactoferrin type. In addition, an immunostain for lactoferrin was positive in the amyloid deposits (Fig. 3f). The background pancreas showed mild chronic pancreatitis. No amyloid deposition was noted in the islets of Langerhans, interstitium or blood vessels of pancreas.

Fig. 2
figure2

a Cyst wall lined by simple mucinous lining epithelium. Hematoxylin and Eosin stain. × 200. be Cyst wall epithelium positive for MUC 5AC and MUC 6 (b, c) and negative for MUC1 and MUC 2 (d, e). Immunostains for MUC5AC, MUC6, MUC1, MUC 2. × 200

Fig. 3
figure3

a Unilocular cyst with mural nodule (arrow). Hematoxylin and Eosin stain. × 20. b Unilocular cyst with mural nodule (arrow). Hematoxylin and Eosin stain. × 40. c Mural nodule composed of amorphous eosinophilic material admixed with chronic inflammation. Hematoxylin and Eosin stain. × 100. d Amorphous material is congophilic, consistent with amyloid. Congo red stain. × 100. e Amyloid deposits with red fluorescence by fluorescence microscopy using Texas red filter. Congo red stain × 100. f Immunostain for lactoferrin, positive in amyloid deposits. × 100

Her post-operative course was uneventful apart from a mild wound seroma requiring only local wound care. She has since been seen multiple times in clinic following surgery and has recovered well.

Discussion and conclusions

Lactoferrin amyloid deposition has never been reported in the pancreas. The case is unique because of unusual presentation of localized amyloidosis as a mural nodule in a 1.6 cm cystic lesion in the head of pancreas, detected by endoscopic ultrasound. As per current international consensus Fukuoka guidelines [18] for management of intraductal papillary mucinous neoplasms of the pancreas, a cyst < 3 cm in size with an enhancing mural nodule on imaging, is considered to be a “cystic lesion with worrisome features”, with a recommendation to proceed with resection in a surgically fit patient without further testing. The premise for this recommendation is that the enhancing mural nodule in the cystic lesion has so far been noted to be an invasive adenocarcinoma developing in mucinous neoplasms. Although we don’t have information about enhancement of mural nodule, ours is a unique case report that shows a mural nodule composed of amyloid lactoferrin deposition and associated giant cell reaction.

The pathogenesis of amyloid lactoferrin in the pancreas remains unclear. This could be secondary to chronic inflammation. Some authors theorize that mutations in lactoferrin cause significant conformational changes prompting the formation of insoluble amyloid fibrils [16, 19]. However, no definitive mechanism has been identified in previous reports of deposits in the cornea, bronchus, and seminal vesicles [14,15,16,17]

Diagnosis frequently requires more than just the initial clinical presentation and thus, imaging is usually necessary. In this case, multiple imaging modalities, including CT, MRI, EUS, and ERCP, were utilized. Only few case reports describe imaging findings associated with amyloidosis of the pancreas. Onur et al. reported CT findings of a diffusely hypoechogenic pancreas with associated enlargement and calcifications [4]. Krishna et al. described a patient with amyloid presenting as a hypoechoic solid mass with anechoic spaces on EUS [20]. None of the findings previously described are unique to amyloid deposition and histopathology is integral to diagnosis.

Amyloid deposition will typically present as amorphous eosinophilic acellular waxy deposits on histopathologic evaluation. When stained with congo red stain, the deposits are congophilic, impart apple green birefringence on polarizing microscopy and show red fluorescence on fluorescent microscopy using Texas Red filter [21]. Though presentation and imaging may suggest alternate diagnoses, histopathological confirmation of amyloidosis is usually necessary, as was the case for this patient.

As diagnosis of lactoferrin amyloid deposition in the pancreas is novel there is no current standard of care for its treatment. In this case, surgical resection was recommended due to the initial concerns for malignancy developing in IPMN/MCN as well as presence of clinical symptoms. Following surgery, the patient has undergone standard post-operative follow-up with no further surveillance specific to her diagnosis suggested. Therefore, appropriate treatment and surveillance likely hinges upon the burden of symptoms experienced by the patient, presence or concern for additional pathology, and whether it represents a localized or systemic process.

In conclusion, localized lactoferrin amyloid deposition in the pancreas presenting, as a mural nodule in an asymptomatic pancreatic cystic lesion is novel. Additional features of lymphadenopathy and atypical cells on FNAC of nodule were concerning for a malignancy, which led to surgical resection. Pathologic evaluation revealed localized amyloid deposition, lactoferrin type, limited to the focus of mural thickening in a simple mucinous cyst lined by gastric type mucinous epithelium. No dysplasia or carcinoma was seen. This is a unique case that adds a new clinical differential to the imaging feature of mural nodule in pancreatic cysts.

Availability of data and materials

Not applicable.

Abbreviations

IAPP:

Islet amyloid polypeptide

PML:

Polymorphonuclear leukocytes

EUS:

Endoscopic ultrasound

mg/dl:

Milligram/deciliter

IU/L:

International units/Litre

ALT:

Alanine aminotransferase

AST:

Aspartate aminotransferase

CBD:

Common bile duct

ERCP:

Endoscopic retrograde cholangiopancreatography

FNA:

Fine needle aspiration

CT:

Computed tomography

MUC 5AC:

Mucin5AC

MUC6:

Mucin6

MUC1:

Mucin1

MUC2:

Mucin2

LMD:

Laser microdissection

LC–MS:

Liquid chromatography–tandem mass spectroscopy

MRI:

Magnetic resonance imaging

IPMN/MCN:

Intraductal papillary mucinous neoplasm/mucinous cystic neoplasm

References

  1. 1.

    Kelly JW. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol. 1998;8(1):101–6.

    CAS  Article  Google Scholar 

  2. 2.

    Benson MD. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995. p. 4159–91.

    Google Scholar 

  3. 3.

    Tan SY, Pepys MB. Amyloidosis. Histopathology. 1994;25(5):403–14.

    CAS  Article  Google Scholar 

  4. 4.

    Onur MR, Yalnız M, Poyraz AK, et al. Pancreatic islet cell amyloidosis manifesting as a large pancreas. Korean J Radiol. 2012;13(1):94–7.

    Article  Google Scholar 

  5. 5.

    Segovia GC, Quilez Barrenechea JI, Vidales Aréchaga L, et al. Pancreatic involvement in primary amyloidosis: radiologic findings. Eur Radiol. 2002;12(4):774–8.

    Article  Google Scholar 

  6. 6.

    Kim D, Crook T, Ramzan Z. An unusual presentation of a benign pancreatic lesion containing amyloid. BMJ Case Rep 2017; 2017. pii: bcr-2017–219861.

  7. 7.

    Vaideeswar P, Chetty R. Amyloidosis of exocrine pancreas. J Postgrad Med. 2011;57(1):61–2.

    CAS  Article  Google Scholar 

  8. 8.

    Vanga RR, Dhingra S, Patel K. Insulin expressing pancreatic neuroendocrine tumor associated with intratumor amyloidosis. Clin Gastroenterol Hepatol. 2017;15(10):A35–6.

    Article  Google Scholar 

  9. 9.

    Ozdemir D, Dagdelen S, Erbas T. Endocrine involvement in systemic amyloidosis. Endocr Pract. 2010;16(6):1056–63.

    Article  Google Scholar 

  10. 10.

    Johansson B. Isolation of an iron containing red protein from human milk. Acta Chem Scand. 1960;14:510–2.

    Article  Google Scholar 

  11. 11.

    Iyer S, Lönnerdal B. Lactoferrin, lactoferrin receptors and iron metabolism. Eur J Clin Nutr. 1993;47:232–41.

    CAS  PubMed  Google Scholar 

  12. 12.

    Broch J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today. 1995;16:417–9.

    Article  Google Scholar 

  13. 13.

    Martins CA, Fonteles MG, Barrett LJ, et al. Correlation of lactoferrin with neutrophilic inflammation in body fluids. Clin Diagn Lab Immunol. 1995;2:763–5.

    CAS  Article  Google Scholar 

  14. 14.

    Tsutsumi Y, Serizawa A, Hori S. Localized amyloidosis of the seminal vesicle: identification of lactoferrin immunoreactivity in the amyloid. Pathol Int. 1996;46(7):491–7.

    CAS  Article  Google Scholar 

  15. 15.

    Ando Y, Nakamura M, Kai H, et al. A novel localized amyloidosis associated with lactoferrin in the cornea. Lab Invest. 2002;82:757–66.

    CAS  Article  Google Scholar 

  16. 16.

    Araki-Sasaki K, Ando Y, Nakamura M, et al. Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br J Ophthalmol. 2005;89(6):684–8.

    CAS  Article  Google Scholar 

  17. 17.

    Ichimata S, Aoyagi D, Yoshinaga T, Katoh N, Kametani F, Yazaki M, Uehara T, Shiozawa S. A case of spheroid-type localized lactoferrin amyloidosis in the bronchus. Pathol Int 2019. https://doi.org/10.1111/pin.12774. [Epub ahead of print]

  18. 18.

    Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–53.

    Article  Google Scholar 

  19. 19.

    Nilsson MR, Dobson CM. In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry. 2003;42(2):375–82.

    CAS  Article  Google Scholar 

  20. 20.

    Krishna SG, Bhutani MS, Mosher CH, et al. A first report of endoscopic ultrasound for the diagnosis of pancreatic amyloid deposition in immunoglobin light chain (AL) amyloidosis (Primary amyloidosis). JOP. 2013;14(3):283–5.

    PubMed  PubMed Central  Google Scholar 

  21. 21.

    Clement CG, Truong LD. An evaluation of Congo red fluorescence for the diagnosis of amyloidosis. Hum Pathol. 2014;45(8):1766–72. https://doi.org/10.1016/j.humpath.2014.04.016.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

No funding support.

Author information

Affiliations

Authors

Contributions

KAB and SD (Dhingra), contributed to manuscript write-up. SD (Desai) contributed to the endoscopic ultrasound study description and image. GVB and WEF, contributed by providing input about the clinical and surgical component of the manuscript, and critically reviewed the manuscript. CAF contributed to the radiology studies and images. SD (Dhingra), contributed to the pathology description and images. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Sadhna Dhingra.

Ethics declarations

Ethical approval and consent to participate

Patient consent obtained.

Consent to publications

Patient provided written consent for the publication of their clinical/patient details and possibly identifying images to be published.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Baugh, K.A., Desai, S., Van Buren 2nd, G. et al. Lactoferrin amyloid presenting as a mural nodule in a pancreatic cystic lesion prompting pancreatoduodenectomy: a case report. BMC Gastroenterol 21, 66 (2021). https://doi.org/10.1186/s12876-021-01641-8

Download citation

Keywords

  • Pancreas
  • Amyloid
  • Mucinous cyst
  • Mural nodule
  • Case report